-
Loading metrics
Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens
- Robert A. Smith,
- Dana N. Raugi,
- Charlotte Pan,
- Matthew Coyne,
- Alexandra Hernandez,
- Brad Church,
- Kara Parker,
- James I. Mullins,
- Papa Salif Sow,
- Geoffrey S. Gottlieb2 for the University of Washington–Dakar HIV-2 Study Group
x
- Published: September 18, 2012
- https://doi.org/10.1371/journal.pone.0045372
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved